Body Mass Index Associated With Colorectal Cancer Mortality Risk

Share this content:
Body mass index at the time of diagnosis and after diagnosis is associated with risk of death in patients with colorectal cancer.
Body mass index at the time of diagnosis and after diagnosis is associated with risk of death in patients with colorectal cancer.

Body mass index (BMI) at the time of diagnosis and after diagnosis is associated with risk of death in patients with colorectal cancer, a study published in JAMA Oncology has shown.1

Although previous research has attempted to determine the relationship between BMI and colorectal cancer outcomes, methodologic limitations have prevented the ability to definitive conclusions. Therefore, researchers sought to evaluate the association of BMI with colorectal cancer mortality in a complete population using causal diagrams.

For the retrospective observational study, investigators analyzed prospectively collected data from 3408 patients diagnosed with stage I to III colorectal cancer between 2006 and 2011 who had undergone surgery.

Results showed that BMI at the time of cancer diagnosis was associated with all-cause mortality, with patients who were underweight and patients who were class 2 or 3 obese demonstrating increased risk of death compared with patients who were low-normal weight.

In contrast, researchers found that patients who were high-normal weight, low-overweight, and high-overweight had lower mortality risks than patients who were low-normal weight. There was no difference in mortality risk between patients who were class 1 obese and those who were low-normal weight.

RELATED: Left-sided Primary Colorectal Tumor Associated With Longer Survival

The study further demonstrated that the risks of colorectal cancer-specific mortality were similar to the risks of all-cause mortality, as was the association between postdiagnosis BMI and mortality; however, patients who were class 1 obese had significantly lower all-cause and cancer-specific mortality risks.

These findings ultimately suggest that recommending weight loss in the immediate period after cancer diagnosis in patients who are overweight may be unwarranted.                         

Reference

  1. Kroenke CH, Neugebauer R, Meyerhardt J, et al. Analysis of body mass index and mortality in patients with colorectal cancer using causal diagrams [published online ahead of print May 19, 2016]. JAMA Oncol. doi: 10.1001/jamaoncol.2016.0732.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters